The drug repurposing service providers market is projected to grow at an annualized rate of 14.7%
Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Market, 2020-2030.”
Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).
To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/drug-repurposing-service-provides/request-sample.html
The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:
- Type of Repurposing Approaches
- Disease-centric approach
- Target-centric approach
- Drug-centric approach
- Therapeutic Area
- Same Therapeutic Area
- Different Therapeutic Area
- Type of Drug Molecule
- Biologics
- Small Molecule
- Key Geographical Region
- North America
- Europe
- Asia-Pacific
- A detailed assessment of the current market landscape of drug repurposing companies
- Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.
- An analysis of the partnerships that have been established in this domain, in the recent past.
- An analysis of the initiatives of big biopharma players engaged in this domain.
- A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.
- A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.
- One of the key objectives of the report was to estimate the existing drug repurposing market size and the future growth potential within the drug repurposing service providers market.
The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
- Auxillis Pharma
- ChemBio Discovery Solutions
- Excelra
- GVK Bio
- Iris Pharma
- Lantern Pharma
- PanXome
- Pharmacelera
- Physiogenex
- Smart Pharma
- Socium
- SOM Biotech
Table of Contents
- Preface
2. Executive Summary
- Introduction
- Market Landscape
- Role of Non-Profit / Academic Organizations
- Company Profiles
- Partnerships
- Big Pharma Initiatives
- Case Study: Discontinued Drug Development Programs
- Cost Saving Analysis
- Market Forecast and Opportunity Analysis
- Covid-19 Impact on Drug Repurposing Service Providers Market
- Recent Advancements and Trends in Outsourcing of Drug Repurposing
- Interview Transcripts
- Appendix 1: List of Potential Drug-Indication Candidates for Drug Repurposing
- Appendix 2: Tabulated Data
- Appendix 3: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com
Facebook – https://www.facebook.com/RootsAnalysis
LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter – https://twitter.com/RootsAnalysis
Medium – https://medium.com/@RootsAnalysis
Pinterest – https://in.pinterest.com/RootsanalysisPin/_saved/
Quora – https://rootsanalysisinsights.quora.com/
